ROPIVACAINE HYDROCHLORIDE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | ROPIVACAINE HYDROCHLORIDE |
| DrugBank ID | DB00296 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 52 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| partial epilepsy | TxGNN Knowledge Graph | L5 |
| partial motor epilepsy | TxGNN Knowledge Graph | L5 |
| classic hodgkin lymphoma | TxGNN Knowledge Graph | L5 |
| obsolete hodgkin's granuloma | TxGNN Knowledge Graph | L5 |
| malignant sertoli-leydig cell tumor of ovary | TxGNN Knowledge Graph | L5 |
| malignant sex cord stromal tumor of ovary | TxGNN Knowledge Graph | L5 |
| hodgkins lymphoma | TxGNN Knowledge Graph | L5 |
| mantle cell lymphoma | TxGNN Knowledge Graph | L5 |
| hereditary breast ovarian cancer syndrome | TxGNN Knowledge Graph | L5 |
| urinary bladder neoplasm | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11